189 related articles for article (PubMed ID: 32914553)
1. Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives.
Prinsloo IF; Zuma NH; Aucamp J; N'Da DD
Chem Biol Drug Des; 2021 Feb; 97(2):383-398. PubMed ID: 32914553
[TBL] [Abstract][Full Text] [Related]
2. Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity.
Ramu D; Garg S; Ayana R; Keerthana AK; Sharma V; Saini CP; Sen S; Pati S; Singh S
Biochem Pharmacol; 2017 Apr; 129():26-42. PubMed ID: 28017772
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antileishmanial efficacy of benzyl analogues of nifuroxazide.
Kannigadu C; Aucamp J; N'Da DD
Drug Dev Res; 2021 Apr; 82(2):287-295. PubMed ID: 33141473
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine-1,1-dioxide derivatives.
Mangwegape DK; Zuma NH; Aucamp J; N'Da DD
Arch Pharm (Weinheim); 2021 May; 354(5):e2000280. PubMed ID: 33491807
[TBL] [Abstract][Full Text] [Related]
5. β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.
Chandrakar P; Gunaganti N; Parmar N; Kumar A; Singh SK; Rashid M; Wahajuddin M; Mitra K; Narender T; Kar S
Eur J Med Chem; 2019 Nov; 182():111632. PubMed ID: 31499363
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis.
Upadhyay A; Chandrakar P; Gupta S; Parmar N; Singh SK; Rashid M; Kushwaha P; Wahajuddin M; Sashidhara KV; Kar S
J Med Chem; 2019 Jun; 62(11):5655-5671. PubMed ID: 31124675
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis of Biaryl Piperidine Derivatives and Their Evaluation as Potential Antileishmanial Agents against Leishmania donovani Strain Ag83.
Rathnakar B; Sinha KK; Prasad SR; Khan MI; Narsaiah C; Rameshwar N; Satyanarayana M
Chem Biodivers; 2021 Jul; 18(7):e2100105. PubMed ID: 34036717
[TBL] [Abstract][Full Text] [Related]
9. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
[TBL] [Abstract][Full Text] [Related]
10. 2-Aryl-quinazolin-4(3H)-ones as an inhibitor of leishmania folate pathway: In vitro biological evaluation, mechanism studies and molecular docking.
Romero AH; Rodríguez N; Oviedo H
Bioorg Chem; 2019 Mar; 83():145-153. PubMed ID: 30359795
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agent.
Yousuf M; Mukherjee D; Dey S; Chatterjee S; Pal A; Sarkar B; Pal C; Adhikari S
Bioorg Med Chem Lett; 2018 Apr; 28(6):1056-1062. PubMed ID: 29478704
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity.
Muhammad MT; Ghouri N; Khan KM; Arshia ; Choudhary MI; Perveen S
Med Chem; 2018; 14(7):725-732. PubMed ID: 29332596
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
16. Antileishmanial structure-activity relationships of synthetic phospholipids: in vitro and in vivo activities of selected derivatives.
Seifert K; Lemke A; Croft SL; Kayser O
Antimicrob Agents Chemother; 2007 Dec; 51(12):4525-8. PubMed ID: 17908944
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
18. Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Hutter S; Castera-Ducros C; Laget M; Remusat V; M'Rabet MK; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2015 Mar; 92():282-94. PubMed ID: 25559208
[TBL] [Abstract][Full Text] [Related]
19. Antileishmanial activity of polycyclic derivatives.
Sarciron ME; Terreux R; Prieto Y; Cortes M; Cuellar MA; Tapia RA; Domard M; Walchshofer N; Pétavy AF
Parasite; 2005 Sep; 12(3):251-8. PubMed ID: 16218213
[TBL] [Abstract][Full Text] [Related]
20. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
